Remote sampling expansion The Mitra VAMS microsampling platform and Harpera Microbiopsy Punch enable reliable remote sample collection across clinical research, therapeutic drug monitoring, remote patient monitoring, and personalized medicine, suggesting strong sales opportunities for decentralized healthcare solutions and global studies.

Clinical research partnerships Trajan has established distributor and partner activity (GenTegra, BioAnalytic, AppMed) and active collaboration with labs and healthcare organizations, indicating receptivity to broadened distribution agreements and regional partnerships to accelerate market reach.

Product roadmap signals Recent launch of HDExaminer PRO v1.0 at ASMS 2026 signals a growing product line and increased instrument integration potential, presenting cross-sell opportunities to labs and CROs seeking advanced microsampling analytics and data workflows.

Strategic leadership changes Executive transitions including the appointment of an Interim CFO and Company Secretary may open dialog for financial collaboration, funding discussions, and potential joint go-to-market initiatives to support scale-up and international expansion.

Distributor network potential Existing distributors across regions (Canada, Poland, etc.) and ongoing partnerships imply room to expand channel sales, add regional distributors, and package with value-added services such as training, case studies, and workflow optimization.